Exact Mass: 260.2378

Exact Mass Matches: 260.2378

Found 149 metabolites which its exact mass value is equals to given mass value 260.2378, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Ropinirole

4-[2-(dipropylamino)ethyl]-2,3-dihydro-1H-indol-2-one

C16H24N2O (260.1889)


Ropinirole is a non-ergoline dopamine agonist, manufactured by GlaxoSmithKline. It is used in the treatment of Parkinsons disease, and is also one of two medications in the United States with an FDA-approved indication for the treatment of restless legs syndrome (the other being Pramipexole). [Wikipedia] D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents > N04BC - Dopamine agonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent

   

Oxymetazoline

3-[(4,5-Dihydro-1H-imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol

C16H24N2O (260.1889)


Oxymetazoline is only found in individuals that have used or taken this drug. It is a direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)Oxymetazoline is a direct acting sympathomimetic amine, which acts on alpha-adrenergic receptors in the arterioles of the conjunctiva and nasal mucosa. It produces vasoconstriction, resulting in decreased conjunctival congestion in ophthalmic. In nasal it produces constriction, resulting in decreased blood flow and decreased nasal congestion. R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AB - Sympathomimetics, combinations excl. corticosteroids R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AA - Sympathomimetics, plain S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics > S01GA - Sympathomimetics used as decongestants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D019141 - Respiratory System Agents > D014663 - Nasal Decongestants D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents D - Dermatologicals

   

5a-androstane

5alpha-androstane

C19H32 (260.2504)


The 5alpha-stereoisomer of androstane.

   

N(4)-bis(aminopropyl)spermidine(1+)

N(4)-bis(aminopropyl)spermidine(1+)

C13H34N5+ (260.2814)


A quaternary ammonium ion that is spermidine carrying two 3-aminopropyl substituents at the N-4 position.

   

3-Dodecyloxypropane-1,2-diol

1,2-Propanediol,3-(dodecyloxy)-

C15H32O3 (260.2351)


D020011 - Protective Agents > D002327 - Cariostatic Agents D001697 - Biomedical and Dental Materials D013501 - Surface-Active Agents

   

3-Gonal

tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecane-5-carbaldehyde

C18H28O (260.214)


   

3-(2-(Diisopropylamino)ethyl)-1H-indol-5-OL

3-{2-[bis(propan-2-yl)amino]ethyl}-1H-indol-5-ol

C16H24N2O (260.1889)


   

5alpha-Androstane

1H-Cyclopenta[a]phenanthrene, hexadecahydro-10,13-dimethyl-, [8S-(8alpha,9beta,10alpha,13alpha,14beta)]-

C19H32 (260.2504)


   

Dodecylglycerol

pentadecane-1,2,3-triol

C15H32O3 (260.2351)


   

Gonal

tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecane-3-carbaldehyde

C18H28O (260.214)


   

(8R,9R,10S,13R,14S)-1,2,3,4,5,6,7,8,9,10,11,12,14,15,16,17-Hexadecahydrocyclopenta[a]phenanthrene-13-carbaldehyde

(8R,9R,10S,13R,14S)-1,2,3,4,5,6,7,8,9,10,11,12,14,15,16,17-Hexadecahydrocyclopenta[a]phenanthrene-13-carbaldehyde

C18H28O (260.214)


   

Anhydrolycocernuine

Anhydrolycocernuine

C16H24N2O (260.1889)


   

3Z,6Z,9Z,18-Nonadecatetraene

3Z,6Z,9Z,18-Nonadecatetraene

C19H32 (260.2504)


   

15,16-Dinorlabda-8(17),11-dien-13-one

15,16-Dinorlabda-8(17),11-dien-13-one

C18H28O (260.214)


   

Dinortrixagone

Dinortrixagone

C18H28O (260.214)


   

n-tridecylbenzene

n-tridecylbenzene

C19H32 (260.2504)


   

ipurolic acid

3,11-dihydroxy-tetradecanoic acid

C14H28O4 (260.1987)


   

(1-Butylnonyl)benzene

(1-Butylnonyl)benzene

C19H32 (260.2504)


   

(1-Ethylundecyl)-benzene

(1-Ethylundecyl)-benzene

C19H32 (260.2504)


   

(1-methyldodecyl)-benzene

(1-methyldodecyl)-benzene

C19H32 (260.2504)


   

(1-Propyldecyl)benzene

(1-Propyldecyl)benzene

C19H32 (260.2504)


   

5-Methoxy EiPT

5-Methoxy EiPT

C16H24N2O (260.1889)


   

5-Methoxy-N-ethyl-n-propyltryptamine

5-Methoxy-N-ethyl-n-propyltryptamine

C16H24N2O (260.1889)


   

N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide

N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide

C16H24N2O (260.1889)


   

3,7,11-trimethyldodecane-1,7,11-triol

3,7,11-trimethyldodecane-1,7,11-triol

C15H32O3 (260.2351)


   

1,3,6,9-nonadecatetraen

1,3,6,9-nonadecatetraen

C19H32 (260.2504)


   
   

N-Demethyl-alpha-obscurine

N-Demethyl-alpha-obscurine

C16H24N2O (260.1889)


   

5-Phenyltridecane

5-Phenyltridecane

C19H32 (260.2504)


   

14,15-dinor-ent-2,4(18)-clerodadien-13-one

14,15-dinor-ent-2,4(18)-clerodadien-13-one

C18H28O (260.214)


   

Ent-15-Nor-3,13-clerodadiene

Ent-15-Nor-3,13-clerodadiene

C19H32 (260.2504)


   

4-Phenyltridecane

4-Phenyltridecane

C19H32 (260.2504)


   
   

ent-kaurene

ent-kaurene

C19H32 (260.2504)


   

14,15-bisnor-3,11E-kolavadien-13-one|ent-14,15-Dinor-3,11-clerodadien-13-one

14,15-bisnor-3,11E-kolavadien-13-one|ent-14,15-Dinor-3,11-clerodadien-13-one

C18H28O (260.214)


   

METHYL 11,11-DIMETHOXYUNDECANOATE

METHYL 11,11-DIMETHOXYUNDECANOATE

C14H28O4 (260.1987)


   

(E)-15,16-Dinor-8(17),12-labdadien-14-al

(E)-15,16-Dinor-8(17),12-labdadien-14-al

C18H28O (260.214)


   

N-Demethyl-α-obscurine

(1R,9S,10R,16R)-16-Methyl-6,14-diazatetracyclo[7.5.3.01,10.02,7]heptadec-2(7)-en-5-one

C16H24N2O (260.1889)


   

Milnacipran,-paramethyl

Milnacipran,-paramethyl

C16H24N2O (260.1889)


   

ropinirole

ropinirole

C16H24N2O (260.1889)


D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents > N04BC - Dopamine agonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent CONFIDENCE standard compound; INTERNAL_ID 2711

   

3,11-dihydroxy myristoic acid

3,11-dihydroxy-tetradecanoic acid

C14H28O4 (260.1987)


   

5-(1-oxopropan-2-yl)isolongifol-5-ene

2-[(1S,8S)-2,2,7,7-tetramethyltricyclo[6.2.1.0(1,6)]undec-5-en-5-yl]propanal

C18H28O (260.214)


   

4,5-(methanoxyethano)isolongifol-4-ene

(1S,12S)-2,2,11,11-tetramethyl-6-oxatetracyclo[10.2.1.0(1,10).0(4,9)]pentadec-4(9)-ene

C18H28O (260.214)


   

6-[5]-ladderane-1-hexanol

6-[5]-ladderane-1-hexanol

C18H28O (260.214)


   

1,3Z,6Z,9Z-Nonadecatetraene

1,3Z,6Z,9Z-Nonadecatetraene

C19H32 (260.2504)


   

3Z,6Z,9Z,11E-Nonadecatetraene

3Z,6Z,9Z,11E-Nonadecatetraene

C19H32 (260.2504)


   

3Z,6Z,9Z,11Z-Nonadecatetraene

3Z,6Z,9Z,11Z-Nonadecatetraene

C19H32 (260.2504)


   

FA 14:0;O2

tetradecanoic acid, 2-methoxy, 4-oxa

C14H28O4 (260.1987)


   

6-[1]-ladderane hexanol

6-[1]-ladderane hexanol

C18H28O (260.214)


   

FOH 18:5

6-[5]-ladderane-1-hexanol

C18H28O (260.214)


   

ST 19:0

5alpha-androstane

C19H32 (260.2504)


   

2-(4-(TERT-BUTYL)PHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE

2-(4-(TERT-BUTYL)PHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE

C16H25BO2 (260.1948)


   

1-(9,9-dimethyldecylsulfanyl)propan-2-ol

1-(9,9-dimethyldecylsulfanyl)propan-2-ol

C15H32OS (260.2174)


   

dibutoxy-(4-ethenylphenyl)borane

dibutoxy-(4-ethenylphenyl)borane

C16H25BO2 (260.1948)


   

1-Chlorohexadecane

1-Chlorohexadecane

C16H33Cl (260.2271)


   

4-BENZYL-2-((PYRROLIDIN-1-YL)METHYL) MORPHOLINE

4-BENZYL-2-((PYRROLIDIN-1-YL)METHYL) MORPHOLINE

C16H24N2O (260.1889)


   

(1R 2S 4R)-(-)-4-(1-METHYLETHYL)-2-(1-M&

(1R 2S 4R)-(-)-4-(1-METHYLETHYL)-2-(1-M&

C18H28O (260.214)


   

1,1,1,3,3-PENTAMETHYL-3-OCTYLDISILOXANE

1,1,1,3,3-PENTAMETHYL-3-OCTYLDISILOXANE

C13H32OSi2 (260.1992)


   

pentadecanoyl chloride

pentadecanoyl chloride

C15H29ClO (260.1907)


   

4-(1-benzyl-piperidin-4-yl)-morpholine

4-(1-benzyl-piperidin-4-yl)-morpholine

C16H24N2O (260.1889)


   

1,1-Bis(tert-butylperoxy)cyclohexane

1,1-Bis(tert-butylperoxy)cyclohexane

C14H28O4 (260.1987)


   

4,4,5,5-tetramethyl-2-(4-phenylbutyl)-1,3,2-dioxaborolane

4,4,5,5-tetramethyl-2-(4-phenylbutyl)-1,3,2-dioxaborolane

C16H25BO2 (260.1948)


   

ETIOCHOLANE

5beta-Androstane

C19H32 (260.2504)


   

4-(2H11)Pentyl-4-biphenylcarbonitrile

4-(2H11)Pentyl-4-biphenylcarbonitrile

C18H8D11N (260.2208)


   

4-Butylphenylboronic acid pinacol ester

4-Butylphenylboronic acid pinacol ester

C16H25BO2 (260.1948)


   

4-(4-butylcyclohexyl)phenylboronic acid

4-(4-butylcyclohexyl)phenylboronic acid

C16H25BO2 (260.1948)


   

decan-1-ol, 2-methyloxirane, oxirane

decan-1-ol, 2-methyloxirane, oxirane

C15H32O3 (260.2351)


   

(17β)-Estr-4-en-17-ol

(17β)-Estr-4-en-17-ol

C18H28O (260.214)


   

t-Hexyl peroxy-2-ethyl hexanoate

t-Hexyl peroxy-2-ethyl hexanoate

C14H28O4 (260.1987)


   

2-(4-Isobutylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-(4-Isobutylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

C16H25BO2 (260.1948)


   

hexadecanoic-5,5,6,6-d4 acid

hexadecanoic-5,5,6,6-d4 acid

C16H28D4O2 (260.2653)


   

Palmitic acid-d4

Palmitic acid-d4

C16H28D4O2 (260.2653)


   

HEXADECANOIC-11,11,12,12-D4 ACID

HEXADECANOIC-11,11,12,12-D4 ACID

C16H28D4O2 (260.2653)


   

N-(1-benzylpiperidin-4-yl)-2-methylpropanamide

N-(1-benzylpiperidin-4-yl)-2-methylpropanamide

C16H24N2O (260.1889)


   

tert-Amyl peroxy 2-ethylhexyl carbonate

tert-Amyl peroxy 2-ethylhexyl carbonate

C14H28O4 (260.1987)


   

2,2-[Ethylenebis(iminotrimethyleneimino)]bis(ethaneamine)

2,2-[Ethylenebis(iminotrimethyleneimino)]bis(ethaneamine)

C12H32N6 (260.2688)


   

1-(4-decylphenyl)ethanone

1-(4-decylphenyl)ethanone

C18H28O (260.214)


   
   

AMyl acetate, Mixture of isoMers

AMyl acetate, Mixture of isoMers

C14H28O4 (260.1987)


   

laurophenone

laurophenone

C18H28O (260.214)


   

4-Hydroxy-N,N-diisopropyltryptamine

4-Hydroxy-N,N-diisopropyltryptamine

C16H24N2O (260.1889)


   

1-(1,1-Dibutoxypropoxy)butane

1-(1,1-Dibutoxypropoxy)butane

C15H32O3 (260.2351)


   

carbonic acid: cyclohexanamine

carbonic acid: cyclohexanamine

C13H28N2O3 (260.21)


   

DODECYLMETHYLSILOXANE, 2-PHENYLPROPYLMETHYLSILOXANE COPOLYMER

DODECYLMETHYLSILOXANE, 2-PHENYLPROPYLMETHYLSILOXANE COPOLYMER

C13H32OSi2 (260.1992)


   

4-(Hydroxymethyl)cyclohexanol

4-(Hydroxymethyl)cyclohexanol

C14H28O4 (260.1987)


   

4,4,5,5-tetramethyl-2-(2-methyl-6-propan-2-ylphenyl)-1,3,2-dioxaborolane

4,4,5,5-tetramethyl-2-(2-methyl-6-propan-2-ylphenyl)-1,3,2-dioxaborolane

C16H25BO2 (260.1948)


   

Nonapyrimine

Nonapyrimine

C15H24N4 (260.2001)


   

1-Methoxy-4-(trans-4-pentylcyclohexyl)benzene

1-Methoxy-4-(trans-4-pentylcyclohexyl)benzene

C18H28O (260.214)


   

Dipropyl-4-hydroxytryptamine

Dipropyl-4-hydroxytryptamine

C16H24N2O (260.1889)


   

1H-Cyclopenta(a)phenanthrene, hexadecahydro-10,13-dimethyl-, (8S-(8alpha,9beta,10alpha,13alpha,14beta))-

1H-Cyclopenta(a)phenanthrene, hexadecahydro-10,13-dimethyl-, (8S-(8alpha,9beta,10alpha,13alpha,14beta))-

C19H32 (260.2504)


   

6-Phenyltridecane

6-Phenyltridecane

C19H32 (260.2504)


   

Acetic acid, dibutoxy-, butyl ester

Acetic acid, dibutoxy-, butyl ester

C14H28O4 (260.1987)


   

Undecanoic acid, 2,3-dihydroxypropyl ester

Undecanoic acid, 2,3-dihydroxypropyl ester

C14H28O4 (260.1987)


   

n-Cyclohexyl-n-(propyl)phenyl urea

n-Cyclohexyl-n-(propyl)phenyl urea

C16H24N2O (260.1889)


   

Androstane

(5R,8S,9S,10S,13S,14S)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene

C19H32 (260.2504)


   

Benzene, (1-butylnonyl)-

Benzene, (1-butylnonyl)-

C19H32 (260.2504)


   

Benzene, (1-propyldecyl)-

Benzene, (1-propyldecyl)-

C19H32 (260.2504)


   

(E,E)-Farnesyl acetone

(E,E)-Farnesyl acetone

C18H28O (260.214)


   

2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17-hexadecahydro-1H-cyclopenta[a]phenanthrene-1-carbaldehyde

2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17-hexadecahydro-1H-cyclopenta[a]phenanthrene-1-carbaldehyde

C18H28O (260.214)


   

(8R,9R,10S,13R,14S)-1,2,3,4,5,6,7,8,9,10,11,12,14,15,16,17-Hexadecahydrocyclopenta[a]phenanthrene-13-carbaldehyde

(8R,9R,10S,13R,14S)-1,2,3,4,5,6,7,8,9,10,11,12,14,15,16,17-Hexadecahydrocyclopenta[a]phenanthrene-13-carbaldehyde

C18H28O (260.214)


   

2-Phenyltridecane

2-Phenyltridecane

C19H32 (260.2504)


   

17-Ketosteroids

17-Ketosteroids

C18H28O (260.214)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

Elaiomycin F

Elaiomycin F

C13H28N2O3 (260.21)


   

1-[4-(2,3-Dimethylphenyl)-1-piperazinyl]-2-methyl-1-propanone

1-[4-(2,3-Dimethylphenyl)-1-piperazinyl]-2-methyl-1-propanone

C16H24N2O (260.1889)


   

(3R)-3,14-dihydroxymyristic acid

(3R)-3,14-dihydroxymyristic acid

C14H28O4 (260.1987)


A dihydroxy monocarboxylic acid that is 17-hydroxymyristic acid in which the pro-R hydrogen beta to the carboxy group is replaced by a hydroxy group.

   

(3R,13R)-3,13-dihydroxymyristic acid

(3R,13R)-3,13-dihydroxymyristic acid

C14H28O4 (260.1987)


An (omega-1)-hydroxy fatty acid that is (13R)-13-hydroxymyristic acid in which the 3-pro-R hydrogen is replaced by a hydroxy group.

   

7,11-Dihydroxytetradecanoic acid

7,11-Dihydroxytetradecanoic acid

C14H28O4 (260.1987)


   

(R)-2-Hydroperoxymyristic acid

(R)-2-Hydroperoxymyristic acid

C14H28O4 (260.1987)


   

3-Phenyltridecane

3-Phenyltridecane

C19H32 (260.2504)


   

16-Fluorohexadecanol

16-Fluorohexadecanol

C16H33FO (260.2515)


   

1-Methoxy-3-(2-trimethylsilyloxyethyl)octane

1-Methoxy-3-(2-trimethylsilyloxyethyl)octane

C14H32O2Si (260.2171)


   

(1-Hydroxy-3-octoxypropan-2-yl) propanoate

(1-Hydroxy-3-octoxypropan-2-yl) propanoate

C14H28O4 (260.1987)


   

(1-Hydroxy-3-nonoxypropan-2-yl) acetate

(1-Hydroxy-3-nonoxypropan-2-yl) acetate

C14H28O4 (260.1987)


   

(+)-1-Monoundecanoin

(+)-1-Monoundecanoin

C14H28O4 (260.1987)


   

(2S,3R,4S)-3-(Tert-butyldimethylsilyloxy)-2,4-dimethylhexanol

(2S,3R,4S)-3-(Tert-butyldimethylsilyloxy)-2,4-dimethylhexanol

C14H32O2Si (260.2171)


   

oxymetazoline

oxymetazoline

C16H24N2O (260.1889)


R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AB - Sympathomimetics, combinations excl. corticosteroids R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AA - Sympathomimetics, plain S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics > S01GA - Sympathomimetics used as decongestants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D019141 - Respiratory System Agents > D014663 - Nasal Decongestants D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents D - Dermatologicals

   

3-Dodecyloxypropane-1,2-diol

1,2-Propanediol,3-(dodecyloxy)-

C15H32O3 (260.2351)


D020011 - Protective Agents > D002327 - Cariostatic Agents D001697 - Biomedical and Dental Materials D013501 - Surface-Active Agents

   

2-methoxy-4-oxatetradecanoic acid

2-methoxy-4-oxatetradecanoic acid

C14H28O4 (260.1987)


   
   

ST 18:1;O

ST 18:1;O

C18H28O (260.214)


   

nonadeca-1,3,6,9-tetraene

nonadeca-1,3,6,9-tetraene

C19H32 (260.2504)


   

(9e,11e,13e,15e)-octadeca-9,11,13,15-tetraenal

(9e,11e,13e,15e)-octadeca-9,11,13,15-tetraenal

C18H28O (260.214)


   

(1s,9r,10s,16s)-16-methyl-6,14-diazatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2(7),5-dien-5-ol

(1s,9r,10s,16s)-16-methyl-6,14-diazatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2(7),5-dien-5-ol

C16H24N2O (260.1889)


   

8-(2,2-dimethyl-6-methylidenecyclohexyl)-6-methylocta-3,5-dien-2-one

8-(2,2-dimethyl-6-methylidenecyclohexyl)-6-methylocta-3,5-dien-2-one

C18H28O (260.214)


   

4-phenylphenyltridecane

NA

C19H32 (260.2504)


{"Ingredient_id": "HBIN010819","Ingredient_name": "4-phenylphenyltridecane","Alias": "NA","Ingredient_formula": "C19H32","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31793","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

4-[(1s,2r,4ar,8as)-1,2,4a-trimethyl-5-methylidene-3,4,8,8a-tetrahydro-2h-naphthalen-1-yl]butan-2-one

4-[(1s,2r,4ar,8as)-1,2,4a-trimethyl-5-methylidene-3,4,8,8a-tetrahydro-2h-naphthalen-1-yl]butan-2-one

C18H28O (260.214)


   

4-(1,2,4a-trimethyl-5-methylidene-3,4,8,8a-tetrahydro-2h-naphthalen-1-yl)butan-2-one

4-(1,2,4a-trimethyl-5-methylidene-3,4,8,8a-tetrahydro-2h-naphthalen-1-yl)butan-2-one

C18H28O (260.214)


   

(1z)-2-[(2s,3s)-3-hydroxy-1-methoxybutan-2-yl]-1-octyldiazen-1-ium-1-olate

(1z)-2-[(2s,3s)-3-hydroxy-1-methoxybutan-2-yl]-1-octyldiazen-1-ium-1-olate

C13H28N2O3 (260.21)


   

(1r,9s,10r,16s)-16-methyl-6,14-diazatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2(7),5-dien-5-ol

(1r,9s,10r,16s)-16-methyl-6,14-diazatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2(7),5-dien-5-ol

C16H24N2O (260.1889)


   

nonadeca-1,10,13,16-tetraene

nonadeca-1,10,13,16-tetraene

C19H32 (260.2504)


   

(3e)-4-[(1r,2r,4ar,8ar)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]but-3-en-2-one

(3e)-4-[(1r,2r,4ar,8ar)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]but-3-en-2-one

C18H28O (260.214)


   

(1s,7s,9s,11s)-11-methyl-2,17-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-13-en-3-one

(1s,7s,9s,11s)-11-methyl-2,17-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-13-en-3-one

C16H24N2O (260.1889)


   

4-[(1r,4ar,8ar)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]but-3-en-2-one

4-[(1r,4ar,8ar)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]but-3-en-2-one

C18H28O (260.214)


   

octadeca-9,11,13,15-tetraenal

octadeca-9,11,13,15-tetraenal

C18H28O (260.214)


   

4-(1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl)but-3-en-2-one

4-(1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl)but-3-en-2-one

C18H28O (260.214)


   

(3e)-4-[(1s,4ar,8as)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]but-3-en-2-one

(3e)-4-[(1s,4ar,8as)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]but-3-en-2-one

C18H28O (260.214)


   

4-(5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)but-3-en-2-one

4-(5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)but-3-en-2-one

C18H28O (260.214)


   

(3e,5e)-8-[(1s)-2,2-dimethyl-6-methylidenecyclohexyl]-6-methylocta-3,5-dien-2-one

(3e,5e)-8-[(1s)-2,2-dimethyl-6-methylidenecyclohexyl]-6-methylocta-3,5-dien-2-one

C18H28O (260.214)


   

16-methyl-6,14-diazatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2(7),5-dien-5-ol

16-methyl-6,14-diazatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2(7),5-dien-5-ol

C16H24N2O (260.1889)


   

(10z,13z,16z)-nonadeca-1,10,13,16-tetraene

(10z,13z,16z)-nonadeca-1,10,13,16-tetraene

C19H32 (260.2504)


   

3,11-dihydroxy-6,8-dimethyldodecanoic acid

3,11-dihydroxy-6,8-dimethyldodecanoic acid

C14H28O4 (260.1987)


   

[(2s,3s)-3-hydroxy-1-methoxybutan-2-yl](octyl-oxo-λ⁵-azanylidene)amine

[(2s,3s)-3-hydroxy-1-methoxybutan-2-yl](octyl-oxo-λ⁵-azanylidene)amine

C13H28N2O3 (260.21)


   

1λ⁵-azabicyclo[13.3.1]nonadeca-1(18),15(19),16-trien-1-ylium

1λ⁵-azabicyclo[13.3.1]nonadeca-1(18),15(19),16-trien-1-ylium

[C18H30N]+ (260.2378)


   

(4-aminobutyl)tris(3-aminopropyl)azanium

(4-aminobutyl)tris(3-aminopropyl)azanium

[C13H34N5]+ (260.2814)


   

(3e)-4-[(1s,4as,8as)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]but-3-en-2-one

(3e)-4-[(1s,4as,8as)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]but-3-en-2-one

C18H28O (260.214)


   

(3e)-4-[(1r,4ar,8ar)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]but-3-en-2-one

(3e)-4-[(1r,4ar,8ar)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]but-3-en-2-one

C18H28O (260.214)


   

(3z,6z,9z)-nonadeca-1,3,6,9-tetraene

(3z,6z,9z)-nonadeca-1,3,6,9-tetraene

C19H32 (260.2504)


   

(3-hydroxy-1-methoxybutan-2-yl)(octyl-oxo-λ⁵-azanylidene)amine

(3-hydroxy-1-methoxybutan-2-yl)(octyl-oxo-λ⁵-azanylidene)amine

C13H28N2O3 (260.21)